Colorado Protein Stability Conference
August 3–6, 2026, Breckenridge, CO, USA
Meet Coriolis Pharma at the Colorado Protein Stability Conference 2026. The Conference brings together experts to discuss the latest insights into protein stability, degradation mechanisms, and analytical approaches.
We are excited to contribute to the scientific program with a presentation by Tim Menzen:
August 4 at 5:25 pm – To platform or not to platform: strategic considerations for antibody formulation in early clinical development.
Brecht Vanbillemont will present a poster on Formulation and Freezing Effects in Lyophilized Viral Vaccines and Amber Raines will contribute with a poster on The research highlights the impact of formulation and freezing strategies on vaccine stability and performance.
Together, these contributions showcase Coriolis Pharma’s expertise in formulation development, analytical characterization, and stability sciences across a wide range of biologic drug products. Visit our booth to meet our experts and discuss how our science-driven approach helps accelerate and de-risk drug product development.
More Events
On-Demand Webinars
March 3, 2025
Developability Assessment and Early Formulation Studies for Biologics
On-Demand Webinars
April 23, 2026
Characterize Your Biologics with Smart and Science-driven Concepts
